CIAS
BIIB icon

CBIZ Investment Advisory Services’s Biogen BIIB Stock Holding History

CBIZ Investment Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51
Closed -$8.97K – 449
2025
Q4 		$8.97K Hold
51
– – ﹤0.01% 400
2025
Q3 		$7.14K Buy
51
+28
+122% +$3.79K ﹤0.01% 396
2025
Q2 		$2.89K Buy
23
+16
+229% +$1.99K ﹤0.01% 502
2025
Q1 		$958 Hold
7
– – ﹤0.01% 521
2024
Q4 		$1.07K Buy
+7
New +$1.18K ﹤0.01% 429

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CBIZ Investment Advisory Services's BIIB Position: Q1 2026 in Review

CBIZ Investment Advisory Services sold out of Biogen (BIIB) in Q1 2026, closing a stake of 51 shares — an estimated $8.97K sold.

CBIZ Investment Advisory Services first reported a position in BIIB in Q4 2024 and held it in 5 quarters. The position peaked at $8.97K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • CBIZ Investment Advisory Services reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 51 Biogen shares in Q1 2026, an estimated $8.97K.
  • CBIZ Investment Advisory Services first reported a position in Biogen in Q4 2024 and held it in 5 quarters.
  • CBIZ Investment Advisory Services's Biogen position peaked at $8.97K in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.